Suppr超能文献

耐甲氧西林金黄色葡萄球菌地方病的控制:重症监护病房的成本效益分析

Control of endemic methicillin-resistant Staphylococcus aureus: a cost-benefit analysis in an intensive care unit.

作者信息

Chaix C, Durand-Zaleski I, Alberti C, Brun-Buisson C

机构信息

Department of Public Health, Créteil, France.

出版信息

JAMA. 1999 Nov 10;282(18):1745-51. doi: 10.1001/jama.282.18.1745.

Abstract

CONTEXT

Despite the success of some countries in controlling endemic methicillin-resistant Staphylococcus aureus (MRSA), such programs have not been implemented for some hospitals with endemic infection because of concerns that these programs would be costly and of limited benefit.

OBJECTIVE

To compare the costs and benefits of an MRSA control program in an endemic setting.

DESIGN AND SETTING

Case-control study conducted at a medical intensive care unit (ICU) of a French university hospital with a 4% prevalence of MRSA carriage at ICU admission.

PATIENTS

Twenty-seven randomly selected patients who had ICU-acquired MRSA infection between January 1993 and June 1997, matched to 27 controls hospitalized during the same period without MRSA infection.

MAIN OUTCOME MEASURES

Intensive care unit costs attributable to MRSA infection, computed from excess therapeutic intensity in cases using estimates from a cost model derived in the same ICU, were compared with costs of the control program, derived from time-motion study of nurses and physicians. The threshold for MRSA carriage that would make the control strategy dominant was determined; sensitivity analyses varied rates of MRSA transmission and ratio of infection to transmission, length of ICU stay, and costs of isolation precautions.

RESULTS

The mean cost attributable to MRSA infection was US $9275 (median, $5885; interquartile range, $1400-$16,720). Total costs of the control program ranged from $340 to $1480 per patient. A 14% reduction in MRSA infection rate resulted in the control program being beneficial. In sensitivity analyses, the control strategy was dominant for a prevalence of MRSA carriage on ICU admission ranging from 1% to 7%, depending on costs of control measures and MRSA transmission, for infection rates greater than 50% following transmission.

CONCLUSIONS

In this example of a hospital with endemic MRSA infection, selective screening and isolation of carriers on ICU admission are beneficial compared with no isolation.

摘要

背景

尽管一些国家在控制地方性耐甲氧西林金黄色葡萄球菌(MRSA)方面取得了成功,但由于担心这些计划成本高昂且效益有限,一些存在地方性感染的医院尚未实施此类计划。

目的

比较在地方性环境中实施MRSA控制计划的成本和效益。

设计与地点

在法国一家大学医院的医疗重症监护病房(ICU)进行的病例对照研究,该ICU入院时MRSA携带率为4%。

患者

1993年1月至1997年6月期间随机选择的27例发生ICU获得性MRSA感染的患者,与同期住院的27例无MRSA感染的对照患者相匹配。

主要观察指标

根据同一ICU中成本模型的估计值,通过病例中额外的治疗强度计算得出的MRSA感染所致重症监护病房成本,与通过护士和医生的时间动作研究得出的控制计划成本进行比较。确定使控制策略占优的MRSA携带阈值;敏感性分析改变了MRSA传播率、感染与传播的比例、ICU住院时间以及隔离预防措施的成本。

结果

MRSA感染所致的平均成本为9275美元(中位数为5885美元;四分位间距为1400 - 16720美元)。控制计划的总成本为每位患者340美元至1480美元。MRSA感染率降低14%使控制计划具有益处。在敏感性分析中,根据控制措施成本和MRSA传播情况,对于传播后感染率大于50%的情况,ICU入院时MRSA携带率在1%至7%范围内时,控制策略占优。

结论

在这家存在地方性MRSA感染的医院的实例中,与不进行隔离相比,在ICU入院时对携带者进行选择性筛查和隔离是有益的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验